Accessibility settings

Published on in Vol 8 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65178, first published .
Alzheimer's disease brain scan with glowing neural pathways and data overlays.

Unsupervised Deep Learning of Electronic Health Records to Characterize Heterogeneity Across Alzheimer Disease and Related Dementias: Cross-Sectional Study

Unsupervised Deep Learning of Electronic Health Records to Characterize Heterogeneity Across Alzheimer Disease and Related Dementias: Cross-Sectional Study

Journals

  1. Fang S, Yin Z, Cai Q, Li L, Zheng P, Chen L. Harnessing artificial intelligence for brain disease: advances in diagnosis, drug discovery, and closed-loop therapeutics. Frontiers in Neurology 2025;16 View
  2. Stern A, Linial M. Integrative machine learning approach to risk prediction for dementia and Alzheimer’s disease. GeroScience 2025;48(2):3007 View
  3. Breithaupt A, Tang A, Paolillo E, Bibars M, Johnson E, Saloner R, Possin K, Windon C, Hill-Jarrett T, Giorgio J, Rauschecker A, Kwon H, Vonk J, Pinheiro-Chagas P. Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias. Seminars in Neurology 2026;46(01):105 View
  4. Zhu M, Liu Y, Luo Z, Zhu T. Bridging data gaps of rare conditions in ICU: a multi-disease adaptation approach for clinical prediction. npj Digital Medicine 2026;9(1) View
  5. Connor B, Hill C, Bai L, McKnight A, Jurek-Loughrey A. Detecting comorbidity patterns in rare disease patients with machine learning. Frontiers in Epidemiology 2026;6 View
  6. Zhang Y, Niu B, Xu W, Hua Y, Xia D. Artificial intelligence reshaping the gout diagnosis and treatment paradigm. Journal of Pharmaceutical Analysis 2026:101702 View
  7. Oishi K, Adams R, Nowrangi M, Zandi P, Lyketsos C. Utilizing routinely acquired clinical neuroimaging and electronic health record data to advance precision medicine in dementia care. International Review of Psychiatry 2026:1 View